CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

Go back to CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
(NASDAQ: VTVT) Delayed: 31.59 --0 (-0%)
Previous Close $31.59    52 Week High $7.70 
Open $31.59    52 Week Low $4.69 
Day High $31.59    P/E N/A 
Day Low $31.59    EPS $0.00 
Volume 3,720